A detailed history of Rhumbline Advisers transactions in Twist Bioscience Corp stock. As of the latest transaction made, Rhumbline Advisers holds 89,054 shares of TWST stock, worth $4.35 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
89,054
Previous 92,897 4.14%
Holding current value
$4.35 Million
Previous $4.58 Million 12.1%
% of portfolio
0.0%
Previous 0.0%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$36.72 - $58.88 $141,114 - $226,275
-3,843 Reduced 4.14%
89,054 $4.02 Million
Q2 2024

Aug 01, 2024

SELL
$27.95 - $53.0 $225,556 - $427,710
-8,070 Reduced 7.99%
92,897 $4.58 Million
Q1 2024

May 09, 2024

BUY
$32.28 - $41.5 $118,564 - $152,429
3,673 Added 3.78%
100,967 $3.46 Million
Q4 2023

Feb 08, 2024

SELL
$15.08 - $38.61 $3,770 - $9,652
-250 Reduced 0.26%
97,294 $3.59 Million
Q3 2023

Nov 09, 2023

SELL
$18.62 - $26.57 $308,570 - $440,318
-16,572 Reduced 14.52%
97,544 $1.98 Million
Q2 2023

Aug 08, 2023

BUY
$11.49 - $20.46 $369,139 - $657,318
32,127 Added 39.18%
114,116 $2.33 Million
Q1 2023

May 11, 2023

BUY
$14.6 - $30.9 $21,491 - $45,484
1,472 Added 1.83%
81,989 $1.24 Million
Q4 2022

Feb 14, 2023

BUY
$21.92 - $39.37 $56,159 - $100,865
2,562 Added 3.29%
80,517 $1.92 Million
Q3 2022

Nov 10, 2022

BUY
$33.44 - $56.56 $170,978 - $289,191
5,113 Added 7.02%
77,955 $2.75 Million
Q2 2022

Aug 11, 2022

BUY
$26.2 - $54.0 $430,570 - $887,436
16,434 Added 29.13%
72,842 $2.55 Million
Q1 2022

May 12, 2022

BUY
$38.58 - $83.27 $235,723 - $508,779
6,110 Added 12.15%
56,408 $2.79 Million
Q4 2021

Feb 10, 2022

SELL
$75.47 - $135.88 $47,772 - $86,012
-633 Reduced 1.24%
50,298 $3.89 Million
Q3 2021

Nov 12, 2021

BUY
$95.64 - $131.48 $113,142 - $155,540
1,183 Added 2.38%
50,931 $5.45 Million
Q2 2021

Aug 05, 2021

SELL
$88.13 - $142.06 $133,076 - $214,510
-1,510 Reduced 2.95%
49,748 $6.63 Million
Q1 2021

May 06, 2021

BUY
$105.48 - $207.97 $1.09 Million - $2.14 Million
10,290 Added 25.12%
51,258 $6.35 Million
Q4 2020

Feb 10, 2021

BUY
$76.64 - $167.89 $146,382 - $320,669
1,910 Added 4.89%
40,968 $5.79 Million
Q3 2020

Nov 12, 2020

SELL
$45.46 - $78.79 $248,757 - $431,138
-5,472 Reduced 12.29%
39,058 $2.97 Million
Q2 2020

Aug 13, 2020

BUY
$26.4 - $45.3 $319,968 - $549,036
12,120 Added 37.4%
44,530 $2.02 Million
Q1 2020

May 06, 2020

BUY
$19.71 - $35.15 $133,180 - $237,508
6,757 Added 26.34%
32,410 $991,000
Q4 2019

Feb 05, 2020

BUY
$21.0 - $26.48 $13,188 - $16,629
628 Added 2.51%
25,653 $539,000
Q3 2019

Oct 23, 2019

BUY
$23.72 - $33.99 $3,320 - $4,758
140 Added 0.56%
25,025 $598,000
Q2 2019

Aug 14, 2019

BUY
$21.74 - $33.2 $540,999 - $826,182
24,885 New
24,885 $722,000

Others Institutions Holding TWST

About Twist Bioscience Corp


  • Ticker TWST
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 56,363,500
  • Market Cap $2.76B
  • Description
  • Twist Bioscience Corporation, a synthetic biology company, manufactures and sells synthetic DNA-based products. The company's DNA synthesis platform enables the manufacturing of synthetic DNA by writing DNA on a silicon chip. It offers synthetic DNA-based products, including synthetic genes, tools for sample preparation, antibody libraries for d...
More about TWST
Track This Portfolio

Track Rhumbline Advisers Portfolio

Follow Rhumbline Advisers and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.